Gold is Hot: Should Investors Be Buying?
SPDR Gold ETF
GLD
What if a space-based mining mission were set up on Psyche that could start bringing back tons of new gold?
Mission to Psyche in 2022, Gets There in 2026
Tesla
TSLA
The Journey to Alnylam
CRISPR Therapeutics
CRSP
Nasdaq Biotech Index
IBB
Global Blood Therapeutics
GBT
Alnylam
ALNY
The Genomic Revolution
Navigating The Healthcare Industry: Science Fiction Turns to Reality
ARK Genomics ETF
ARKG
What to Do Before the Machines Take Over
Facebook Faceplant: First AI Failure, More to Come
Kevin Cook is a Senior Stock Strategist for Zacks Investment Research where he runs the Healthcare Innovators portfolio.
Click to get this free report
Tesla, Inc. (TSLA): Free Stock Analysis Report
iShares Nasdaq Biotechnology ETF (IBB): ETF Research Reports
SPDR Gold Shares (GLD): ETF Research Reports
Global Blood Therapeutics, Inc. (GBT): Free Stock Analysis Report
CRISPR Therapeutics AG (CRSP): Free Stock Analysis Report
ARK Genomic Revolution ETF (ARKG): ETF Research Reports
Alnylam Pharmaceuticals, Inc. (ALNY): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Click to get this free report
Tesla, Inc. (TSLA): Free Stock Analysis Report
iShares Nasdaq Biotechnology ETF (IBB): ETF Research Reports
SPDR Gold Shares (GLD): ETF Research Reports
Global Blood Therapeutics, Inc. (GBT): Free Stock Analysis Report
CRISPR Therapeutics AG (CRSP): Free Stock Analysis Report
ARK Genomic Revolution ETF (ARKG): ETF Research Reports
Alnylam Pharmaceuticals, Inc. (ALNY): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.